Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Bioinformatics Investigation of Hub Genes Involved in Treg Migration and Its Synergistic Effects, Using Immune Checkpoint Inhibitors for Immunotherapies. | Int J Mol Sci | 2024 | 39273290 | PubTator, text mining | PubMed |
| Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistance. | Clin Exp Med | 2024 | 39261380 | PubTator, text mining | PubMed |
| Role of chemokine receptors in gastrointestinal mucosa. | Int Rev Cell Mol Biol | 2024 | 39260937 | PubTator, text mining | PubMed |
| The chemokine receptor CCR8 is not a high-affinity receptor for the human chemokine CCL18. | PLoS One | 2024 | 39259753 | PubTator, text mining | PubMed |
| Dissecting the Distinct Tumor Microenvironments of HRD and HRP Ovarian Cancer: Implications for Targeted Therapies to Overcome PARPi Resistance in HRD Tumors and Refractoriness in HRP Tumors. | Adv Sci (Weinh) | 2024 | 39136172 | PubTator, text mining | PubMed |
| CCL16 is a pro-tumor chemokine that recruits monocytes and macrophages to promote hepatocellular carcinoma progression. | Am J Cancer Res | 2024 | 39113854 | PubTator, text mining | PubMed |
| Bioactive Materials That Promote the Homing of Endogenous Mesenchymal Stem Cells to Improve Wound Healing. | Int J Nanomedicine | 2024 | 39099796 | PubTator, text mining | PubMed |
| Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer. | J Transl Med | 2024 | 39080766 | PubTator, text mining | PubMed |
| Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis. | Nat Cardiovasc Res | 2024 | 39044999 | PubTator, text mining | PubMed |
| Targeting the glucocorticoid receptor-CCR8 axis mediated bone marrow T cell sequestration enhances infiltration of anti-tumor T cells in intracranial cancers. | Cell Mol Immunol | 2024 | 39044027 | PubTator, text mining | PubMed |
| Cross-talk between ILC2 and Gata3high Tregs locally constrains adaptive type 2 immunity. | Sci Immunol | 2024 | 39028828 | PubTator, text mining | PubMed |
| Cryo-EM Structure and Biochemical Analysis of the Human Chemokine Receptor CCR8. | Biochemistry | 2024 | 38985857 | PubTator, text mining | PubMed |
| Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104). | Cell Rep Med | 2024 | 38897205 | PubTator, text mining | PubMed |
| Selective depletion of tumor-infiltrating regulatory T cells with BAY 3375968, a novel Fc-optimized anti-CCR8 antibody. | Clin Exp Med | 2024 | 38856863 | PubTator, text mining | PubMed |
| Epitope Mapping of an Anti-Mouse CCR8 Monoclonal Antibody C8Mab-2 Using Flow Cytometry. | Monoclon Antib Immunodiagn Immunother | 2024 | 38836509 | PubTator, text mining | PubMed |
| In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications. | BMC Cancer | 2024 | 38783281 | PubTator, text mining | PubMed |
| Chemokine receptor hetero-oligomers regulate monocyte chemotaxis. | Life Sci Alliance | 2024 | 38782603 | PubTator, text mining | PubMed |
| Sensing antibody functions with a novel CCR8-responsive engineered cell. | Acta Biochim Pol | 2024 | 38721308 | PubTator, text mining | PubMed |
| Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis. | Am J Respir Crit Care Med | 2024 | 38717443 | PubTator, text mining | PubMed |
| The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab. | ESMO Open | 2024 | 38703428 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=6